About Bon Vivant
Bon Vivant is a company based in Paris (France) founded in 2022 by Helene BRIAND and Stephane Mac Millan. Bon Vivant has raised $20.34 million across 2 funding rounds from investors including Sofinnova Partners, Sparkfood and Alliance for Impact. Bon Vivant offers products and services including FermWhey™ Native, FermWhey™ MicroStab, FermWhey™ Gel, GelFactor™, and MicroFactor™. Bon Vivant operates in a competitive market with competitors including Nutropy and Nature & Moi, among others.
- Headquarter Paris, France
- Founders Helene BRIAND, Stephane Mac Millan
-
Sectors
Consumer
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bon Vivant
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$20.34 M (USD)
in 2 rounds
-
Latest Funding Round
$15.95 M (USD), Seed
Oct 25, 2023
-
Investors
Sofinnova Partners
& 10 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bon Vivant
Bon Vivant offers a comprehensive portfolio of products and services, including FermWhey™ Native, FermWhey™ MicroStab, FermWhey™ Gel, GelFactor™, and MicroFactor™.
Sustainable protein for enhanced dairy functionality and nutrition.
Stabilized protein for improved texture in food applications.
Gel-based protein for superior flavor and structural integrity.
Technology component for reducing greenhouse gas emissions in proteins.
Process for minimizing water use in dairy protein production.
People of Bon Vivant
Unlock access to complete
Funding Insights of Bon Vivant
Bon Vivant has successfully raised a total of $20.34M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $15.95 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bon Vivant
Bon Vivant has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Sofinnova Partners, Sparkfood and Alliance for Impact.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sofinnova Partners is focused on life sciences and healthcare investments.
|
Locked | Locked | Locked | |
|
High Flyers Capital is focused on food sector investments.
|
Locked | Locked | Locked | |
|
Seed-stage investments in startups are provided by Kima Ventures.
|
Locked | Locked | Locked |
Investor details for Bon Vivant
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bon Vivant
Investment portfolio details for Bon Vivant
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bon Vivant
Detailed financials for Bon Vivant
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bon Vivant Comparisons
Peer comparison for Bon Vivant
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bon Vivant
Bon Vivant operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nutropy and Nature & Moi, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Microbe-based cheeses are developed without animal milk using microorganisms.
|
|
| Locked | Locked | Locked |
Plant-based cheese alternatives are offered via an online platform.
|
Detailed competitors of Bon Vivant
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bon Vivant
Complete news archive for Bon Vivant
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bon Vivant
Bon Vivant was founded in 2022.
Bon Vivant is headquartered in Paris, France.
Stephane Mac Millan is the current CEO of Bon Vivant. They have also founded this company.
Bon Vivant is a funded company, having raised a total of $20.34M across 2 funding rounds to date.
Bon Vivant was founded in 2022 in Paris, France, within the food technology sector focused on alternative proteins. Precision fermentation is employed to program yeasts for producing milk proteins, which are then cultivated in a vegetable-based medium. This process yields pure animal-free alternatives suitable for cheese and other dairy products, addressing demand in the sustainable food industry.
Bon Vivant's top competitors include Nutropy and Nature & Moi.
Bon Vivant offers FermWhey™ Native, FermWhey™ MicroStab, FermWhey™ Gel, GelFactor™, and MicroFactor™.
Bon Vivant has 11 investors. Key investors include Sofinnova Partners, Sparkfood, Alliance for Impact, High Flyers Capital, and Kima Ventures.